Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension - Galiè, N; Gaine, S; Channick, R (Adv Ther, 2022)
et al.